Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Abroad (travel likely)RecruitingPHASE2

Conditions

Optic Neuritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Ari Green, MD, MCR

    Principal Investigator

    University of California, San Francisco